Skip to main content
. Author manuscript; available in PMC: 2021 Jul 8.
Published in final edited form as: Cardiology. 2021 Apr 26;146(4):481–488. doi: 10.1159/000515064

Table 1:

Comparison of demographics and underlying cardiovascular comorbidities of patients with COVID-19 admitted to Texas and New York State hospitals

Texas (N=296, 58%) New York State (N=218, 42%) p-value **
Female, n (%) 165 (56.3) 103 (48.1) 0.068
Age, years, median (IQR)* 57 (47-66) 63 (51-77) <.0.001
Age group, n (%) <.0.001
 <40 years 49 (16.6) 31 (14.2)
 40-49 years 46 (15.5) 20 (9.2)
 50-59 years 77 (26.0) 37 (17.0)
 60-69 years 62 (21.0) 48 (22.0)
 70-79 years 42 (14.2) 38 (17.4)
 80+ years 20 (6.8) 44 (20.2)
Race, n (%) <.0.001
 White 146 (49.3) 156 (71.6)
 Black 88 (29.7) 24 (11)
 Asian 9 (3.0) 7 (3.2)
 Other 53 (17.9) 31 (14.2)
Hispanic ethnicity, n (%) 127 (43.2) 14 (6.6) <.0.001
BMI, kg/m2, median (IQR)* 30.3 (25.9 - 35.9) 28.49 (24.5 - 34.01) 0.015
Insurance, n(%) <0.001
 Private 97 (33.0) 50 (23.1)
 Medicare 65 (22.1) 93 (43.1)
 Medicaid 14 (4.8) 49 (22.7)
 Uninsured 65 (22.1) 3 (1.4)
Positive history of, n (%)
 Hypertension 174 (58.8) 112 (51.4) 0.095
 Heart failure 31 (10.5) 26 (11.9) 0.604
 Coronary artery disease 30 (10.1) 41 (18.8) 0.005
 Atrial fibrillation 14 (4.7) 23 (10.6) 0.012
 Stroke 20 (6.8) 21 (9.6) 0.234
 Diabetes Mellitus 121 (40.9) 66 (30.3) 0.014
 Lung disease 34 (11.5) 33 (15.1) 0.224
 Dyslipidemia 93 (31.4) 61 (28.0) 0.400
 Cancer 13 (4.4) 19 (8.7) 0.045
 Smoking exposure 87 (33.0) 65 (30.0) 0.481
*

IQR = inter-quartile range

**

p-values from chi-square tests, except for Age and BMI (Mann-Whitney test)